Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57893 participants
INTERVENTIONAL
2022-12-08
2022-12-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Vaccination Take-Up
NCT04867174
Incentives & Motivation for Behavior Change:
NCT04747327
Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities
NCT04901624
Does Framing and Humor Improve the Effectiveness of Messages About COVID-19 Vaccine
NCT05085613
Non-integrated Costs Increase Effectiveness of Incentives
NCT03507231
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Message Only
Email or SMS Booster Vaccination Reminder
Messaging
Booster reminder message
Message + Financial Incentive
Email or SMS Booster Vaccination Reminder + Offer of a financial incentive for getting boosted in the next 2 weeks.
Messaging
Booster reminder message
Financial Incentive
Financial Incentive for getting boosted within 2-weeks of the message
Control
No message or financial incentive
Placebo
Treatment as usual; no additional message and no incentive.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Messaging
Booster reminder message
Financial Incentive
Financial Incentive for getting boosted within 2-weeks of the message
Placebo
Treatment as usual; no additional message and no incentive.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. At least one COVID-19 vaccination (primary series or monovalent booster) but no vaccination dose within the past 2-months.
3. Active phone number or email
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
J-PAL North America
UNKNOWN
University of Southern California
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mireille Jacobson
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Contra Costa Health Plan
Martinez, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UP-21-01097
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.